Harvest Health & Recreation Inc. Reports Second Quarter 2021 Financial Results

  • Second quarter revenue was $102.5 million , up 84% from the second quarter 2020 and 15% sequentially
  • Second quarter net loss before non-controlling interest was $19.2 million , compared to $23.0 million in the first quarter 2021
  • Adjusted EBITDA was $28.0 million in the second quarter, compared to $26.9 million in the first quarter 2021
  • 2021 revenue target of at least $400 million maintained

Harvest Health & Recreation Inc. ("Harvest" or the "Company") ( CSE: HARV OTCQX: HRVSF ), a vertically integrated cannabis company and multi-state operator in the U.S., today reported its financial and operating results for the second quarter 2021. All financial information is provided in U.S. dollars unless otherwise indicated.

Second Quarter 2021 Financial Results

  • Total revenue in the second quarter was $102.5 million , an increase of 84% from $55.7 million in the second quarter of 2020, and up 15% compared to $88.8 million in the first quarter of 2021.
  • Gross profit in the second quarter was $52.3 million , compared to $23.4 million in the second quarter of 2020, and $47.9 million in the first quarter of 2021.
  • Gross profit margin in the second quarter was 51.0%, compared to 42.1% in the second quarter of 2020 and 53.9% in the first quarter of 2021.
  • Net loss before non-controlling interest was $19.2 million for the second quarter, compared to $23.0 million in the first quarter of 2021.
  • Adjusted EBITDA in the second quarter was $28.0 million , compared to $26.9 million in the first quarter of 2021.

Please see the supplemental information regarding the use of Non-GAAP Financial Measures, and a reconciliation of Non-GAAP Financial Measures.

Second Quarter 2021 Business Highlights

  • On May 10, 2021 , Trulieve announced its planned acquisition of Harvest. Each Harvest shareholder is expected to receive 0.1170 shares of Trulieve for each Harvest share, representing total consideration of approximately $2.1 billion and a 34% premium to the May 7, 2021 closing price of the Harvest shares.
  • On May 7, 2021 , Harvest announced that a settlement was reached regarding the grower/processor permittee AGRiMED Industries of PA, LLC.
  • Harvest opened four new medical retail dispensaries in Florida in Lehigh Acres , North Miami Beach , Olympia Heights, and West Palm Beach and one new medical retail dispensary in York , Pennsylvania .
  • As of June 30, 2021 , Harvest owned, operated, or managed 42 retail locations in five states, including 15 open dispensaries in Arizona .

Recent Developments

  • In July, Harvest announced the conversion of the exercise price of select warrants to U.S. dollars and the acceleration of the expiry date of warrants issued in October 2020 .
  • On July 12, 2021 , Harvest filed a definitive proxy statement with the Securities and Exchange Commission and SEDAR for its annual and special shareholder meeting to be held on August 11, 2021 .
  • On July 15, 2021 , Harvest announced the divestiture of cultivation and processing assets in Utah for an immaterial amount of cash.
  • Harvest opened one new medical retail dispensary on July 15 th in South Miami Beach, Florida .
  • Harvest opened one new dispensary serving medical patients and adult use customers on August 6 th in Mesa, Arizona .
  • As of August 10, 2021 , Harvest owned, operated, or managed 44 retail locations in five states, including 16 open dispensaries in Arizona .

Outlook
Harvest is maintaining its full year 2021 revenue target of at least $400 million . Reported gross margins are expected to be at or above 50% and will likely continue to fluctuate from quarter to quarter.

Management Commentary
"Our second quarter results demonstrate continued momentum as Harvest builds scale and expands in its core markets" said Chief Executive Officer Steve White . "We are focused on our key operational and financial priorities in 2021 as we work toward closing the pending acquisition by Trulieve."

Conference Call & Webcast
Harvest Health and Recreation Inc. will host a conference call and audio webcast with Chief Executive Officer Steve White , Tuesday August 10, 2021 at 5:00 PM Eastern Time .

Registration for this event is required. Please use this link to register:
https://www.directeventreg.com/registration/event/5996545

Following registration, an email confirmation will be sent including dial in details and unique conference call codes. Registration will remain open during the call however we recommend advance registration to access the event.

Second quarter results will be available at:
https://investor.harvesthoc.com/financials/default.aspx

The live conference call webcast and replay will be available at:
https://investor.harvesthoc.com/financials/default.aspx

HARVEST HEALTH & RECREATION INC.

Consolidated Balance Sheets

(Amounts expressed in thousands of United States dollars, except share data)



June 30,

2021


December 31,

2020

ASSETS






Current assets:






Cash and cash equivalents

$

71,064


$

78,055

Restricted cash


3,000



4,542

Accounts receivable, net


8,788



5,051

Notes receivable, current portion


9,593



21,556

Related party notes receivable, current portion


10,276



10,052

Inventory, net


44,608



36,862

Other current assets


8,125



5,280

Total current assets


155,454



161,398

Notes receivable, net of current portion


10,516



18,211

Property, plant and equipment, net


179,182



176,827

Right-of-use assets for operating leases, net


113,395



60,843

Related party right-of-use assets for operating leases, net


5,541



5,621

Intangible assets, net


272,083



272,118

Corporate investments


40,924



19,091

Acquisition deposits


50



50

Goodwill


115,541



116,041

Assets held for sale


3,689



6,585

Other assets


19,672



19,850

TOTAL ASSETS

$

916,047


$

856,635

LIABILITIES AND STOCKHOLDERS' EQUITY






LIABILITIES






Current liabilities:






Accounts payable

$

7,988


$

10,755

Other current liabilities


30,434



28,896

Contingent consideration, current portion


10,398



17,985

Income tax payable


10,642



17,504

Operating lease liability, current portion


1,910



2,906

Related party operating lease liability, current portion


150



135

Notes payable, current portion


134,394



20,910

Total current liabilities


195,916



99,091

Notes payable, net of current portion


144,248



244,066

Warrant liability


3,438



20,908

Operating lease liability, net of current portion


112,731



58,637

Related party operating lease liability, net of current portion


5,518



5,595

Deferred tax liability


53,082



53,082

Total liabilities associated with assets held for sale


28



718

Other long-term liabilities


11



63

TOTAL LIABILITIES


514,972



482,160

STOCKHOLDERS' EQUITY






Capital stock


736,901



667,248

Accumulated deficit


(336,234)



(293,607)

Stockholders' equity attributed to Harvest Health & Recreation Inc.


400,667



373,641

Non-controlling interest


408



834

TOTAL STOCKHOLDERS' EQUITY


401,075



374,475

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

916,047


$

856,635

HARVEST HEALTH & RECREATION INC.

Consolidated Statements of Operations

(Amounts expressed in thousands of United States dollars, except share and per share data)



For the three months ended June 30,


2021


2020

Revenue, net of discounts

$

102,463


$

55,661

Cost of goods sold


(50,201)



(32,246)

Gross profit


52,262



23,415

Expenses






General and administrative


33,126



26,940

General and administrative, related party operating lease expense


201



200

Sales and marketing


1,224



1,248

Share-based compensation


3,741



3,276

Depreciation and amortization


2,641



725

Total expenses


40,933



32,389

Operating income (loss)


11,329



(8,974)

Other (expense) income






Loss on sale of assets


(21)



(2,783)

Other income


269



1,205

Fair value of liability adjustment


(8,353)



(1,497)

Fair value of contingent consideration


(4,500)



Foreign currency gain


17



30

Interest expense


(9,182)



(9,169)

Contract asset impairment




(2,420)

Loss before taxes and non-controlling interest


(10,441)



(23,608)

Income taxes


(6,834)



(1,132)

Net loss from continuing operations before non-controlling interest


(17,275)



(24,740)

Net loss from discontinued operations, net of tax


(1,954)



(905)

Net loss before non-controlling interest


(19,229)



(25,645)

Net income attributed to non-controlling interest


(276)



(1,929)

Net loss attributed to Harvest Health & Recreation Inc.

$

(19,505)


$

(27,574)

Net loss per share – basic and diluted

$

(0.04)


$

(0.07)

Attributable to Harvest Health and Recreation Inc.

$

(0.05)


$

(0.07)

Attributable to discontinued operations, net of tax

$

(0.00)


$

(0.00)

Weighted-average shares outstanding - basic and diluted


413,103,779



364,580,737

Use of Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures as defined by the SEC. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with GAAP are included below. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP. Our management uses adjusted EBITDA to evaluate our operating performance and trends and make planning decisions. Our management believes adjusted EBITDA helps identify underlying trends in our business that could otherwise be masked by the effect of the items that we exclude. Accordingly, we believe that adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by our management in its financial and operational decision-making.

Reconciliation of Non-GAAP Financial Measures
The table below reconciles Net loss to Adjusted EBITDA for the periods indicated.


For the three months ended June 30,

(Amounts expressed in thousands of United States dollars)

2021


2020

Net loss (GAAP) before non-controlling interest

$

(19,229)


$

(25,645)

Add (deduct) impact of:






Net interest and other financing costs (1)


9,184



9,390

Income tax


6,834



1,132

Amortization and depreciation (2)


3,532



1,803

Loss on sale of assets


21



2,783

Fair value of liability adjustment


8,353



1,497

Fair value of contingent consideration


4,500



Other income


(269)



(1,205)

Foreign currency gain


(17)



(30)

Share-based compensation expense


3,741



3,276

Contract asset impairment




2,420

Discontinued operations, net of tax


1,954



905

Other expansion expenses (pre-open)


3,371



2,323

Transaction & other special charges


6,047



956

Adjusted EBITDA (non-GAAP)

$

28,022


$

(395)


(1) Includes less than $0.1 million and $0.2 million of interest reported in cost of sales for the three months ended June 30, 2021 and 2020, respectively

(2) Includes $1.1 million and $0.9 million of depreciation reported in cost of sales for the three months ended June 30, 2021 and 2020, respectively

Forward-looking Statements
This press release contains "forward-looking statements," within the meaning of United States and Canadian securities laws. Such statements reflect current estimates, expectations and projections about future events and involve risks and uncertainties relating to future events and Harvest's performance, and actual events may differ materially from these forward looking statements, which may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions. These forward looking statements include, without limitation, including statements regarding Trulieve Cannabis Corp.'s ("Trulieve") and Harvest's strategic business combination and the expected terms, timing and closing of the combination, estimates of pro-forma financial information of the combined company, Trulieve's and Harvest's expected financial performance for fiscal 2021, the combined operations and prospects of Trulieve and Harvest, the current and projected market and growth opportunities for the combined company and value for shareholders; current and anticipated shareholder demands and litigation in connection with the proposed transaction; our expectations for 2021 financial performance and targeted revenue and gross margin; prospects for revenue growth and profitability in our core markets and in the U.S. cannabis industry generally; our continued growth in retail dispensary openings, same store sales growth, recreational sales in Arizona , and expanded cultivation and manufacturing operations; the development of federal and state cannabis regulatory framework in the United States applicable to multi-state operators, including a delay in, or a failure to, federally decriminalize cannabis in the United States , as well as such frameworks in Harvest's core markets; adverse changes in the application or enforcement of current laws, including those related to taxation; adverse changes in the public perception of cannabis; the effects of the weather, natural disasters, and health pandemics, including recent renewed resurgence of the novel coronavirus (COVID-19) on customer demand, Harvest's supply chain as well as its consolidated results of operation, financial position and cash flows; the ability of Harvest to develop Harvest's brand and meet its growth, revenue and profitability projections and objectives; its ability to generate sufficient cash flow to repay debt obligations and to fund operating expenses and future investment; the ability of Harvest to complete planned acquisitions that are accretive to its revenue; the ability of Harvest to obtain and/or maintain licenses to operate in the jurisdictions in which it operates or in which it expects or plans to operate; changes in general economic, business and political conditions, including changes in the financial markets, and, in particular, the ability of Harvest to raise debt and equity capital in the amounts and at the costs that it expects; the ability to locate and acquire suitable companies, properties or assets necessary to execute on Harvest's business plans; the ability of Harvest to execute planned store openings and secure cannabis supply at appropriate amounts and cost; fluctuations in the prevailing prices for cannabis and cannabis products in the markets that Harvest operates in and sources supply; its ability to resolve existing and future litigation and arbitrations on acceptable terms; and increasing costs of compliance with extensive government regulation. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. In addition, even if the outcome and financial effects of the plans and events described herein are consistent with the forward-looking statements contained in this document, those results or developments may not be indicative of results or developments in subsequent periods.

Forward-looking statements involve significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements. Please see the heading "Risk Factors" in Harvest's Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission and in Harvest's Annual Information Circular, which was filed on SEDAR, both of which were filed on March 30, 2021 , and in our Form 10-Q for the quarter ended March 31, 2021 , which was filed with the SEC and SEDAR on May 13, 2021 , and in all subsequent filings that Harvest makes with the Securities and Exchange Commission and SEDAR, for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. Harvest does not undertake to update any forward-looking statements that are included herein, except in accordance with applicable securities laws.

About Harvest Health & Recreation Inc.
Headquartered in Tempe, Arizona , Harvest Health & Recreation Inc. is a vertically integrated cannabis company and multi-state operator. Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries. Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S. Harvest's mission is to improve lives through the goodness of cannabis. We hope you'll join us on our journey:   https://harvesthoc.com  

Facebook: @HarvestHOC
Instagram: @HarvestHOC
Twitter: @HarvestHOC

Cision View original content: https://www.prnewswire.com/news-releases/harvest-health--recreation-inc-reports-second-quarter-2021-financial-results-301352511.html

SOURCE Harvest Health & Recreation Inc.

Cision View original content: https://www.newswire.ca/en/releases/archive/August2021/10/c4620.html

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)
Cannabis leaves, US flag.

Cannabis Round-Up: Harris  to Push for Federal Legalization, DEA Choosing Witnesses for Rescheduling Trial

October brought new developments in the cannabis and hemp industries, with Georgia's Hemp Farming Act coming into effect on October 1.

In California, Governor Newsom signed a bill legalizing Amsterdam-esque cannabis cafes, which will allow dispensaries to serve food and drinks and host live entertainment.

Meanwhile, Kentucky held its first lottery for medical cannabis business licenses as the DEA prepared to hold a hearing on rescheduling cannabis, and Vice President Harris included cannabis legalization in her policy agenda.

Keep reading...Show less

Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company's website.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Lake Placid, Florida

New Highlands County location will host grand opening celebration Friday, November 1 st

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Lake Placid, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve to Open Florida Medical Cannabis Dispensaries in Bonita Springs and St. Augustine

Grand opening celebrations scheduled for Friday, October 18 th

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of new Florida medical cannabis dispensaries in Bonita Springs and St. Augustine .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Cannabis Corp. to Hold Third Quarter 2024 Results Conference Call on November 5, 2024

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Tuesday, November 5, 2024 at 8:30 AM Eastern Time following the release of its third quarter 2024 financial results.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

Chairman, Founder, and Chief Executive Officer Kim Rivers and Chief Financial Officer Wes Getman will participate on the call to review Trulieve's financial and operating results.

Interested parties can join the conference call by dialing in as directed below. Please dial in 15 minutes prior to the call and ask to join the Trulieve Cannabis Corp. call.

North American toll free: 1-844-824-3830


Passcode:


3735709


International: 1-412-542-4136


Passcode:


3735709


A live audio webcast of the conference call will be available at:
Trulieve Third Quarter 2024 Results Call

An archived replay of the webcast will be available at:
https://investors.trulieve.com/events

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
X: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-cannabis-corp-to-hold-third-quarter-2024-results-conference-call-on-november-5-2024-302274503.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2024/14/c7404.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Spinach® Is the Number One Cannabis Brand in Canada

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos"), an innovative global cannabinoid company, is proud to announce that its award-winning brand Spinach® has risen to the best-selling cannabis brand in the Canadian market. 1 Spinach's market share outperformance represents Cronos' relentless commitment to quality, innovation, and bringing differentiated products to the competitive Canadian adult-use market.

Since launching in November 2018, Spinach has quickly become the preferred choice among new and seasoned adult consumers alike. The success of Spinach is bolstered by its best-selling and breakthrough portfolio of products, including ranking first in both edibles and flower. 1

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×